CIK 0001671502 · Non-accelerated filer<br>Smaller reporting company
Quoin Pharmaceuticals Ltd.
Sign in to watch- Ticker
- QNRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 703 980 4182
- Business address
- 42127 PLEASANT FOREST COURT, ASHBURN, VA, 20148-7349
- Former names
- Quoin Pharmaceuticals, Ltd., Cellect Biotechnology Ltd., Cellect Biomed Ltd.
- 4 Open-market buy Chief Operating Officer bought 20,490 shares at $4.88 ($99,991)
- 4 Open-market buy Chief Executive Officer bought 20,490 shares at $4.88 ($99,991)
- 4 Open-market buy Chief Financial Officer bought 10,244 shares at $4.88 ($49,991)
- 4 Open-market buy Director bought 6,146 shares at $4.88 ($29,992)
- 4 Grant or award Director acquired 34,534 shares (grant or award)
- 4 Grant or award Director acquired 31,352 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- 8-K Event Executive or director change · Shareholder vote results · Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 424B3 Offering Prospectus
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 2 of 30 · 585 filings